Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH.

Diabetes Care. 2003 Apr;26(4):1258-64.

PMID:
12663607
2.

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

JAMA. 2002 May 15;287(19):2563-9.

3.

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM.

N Engl J Med. 2000 Feb 10;342(6):381-9. Erratum in: N Engl J Med 2000 May 4;342(18):1376.

8.

The cellular and molecular mechanisms of diabetic complications.

King GL, Brownlee M.

Endocrinol Metab Clin North Am. 1996 Jun;25(2):255-70. Review.

PMID:
8799700
9.

Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected].

Molitch ME, Steffes MW, Cleary PA, Nathan DM.

Kidney Int. 1993 Mar;43(3):668-74. Erratum in: Kidney Int 1993 May;43(5):1196.

10.

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C.

N Engl J Med. 1993 Sep 30;329(14):977-86.

11.

Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group.

Levey AS, Greene T, Schluchter MD, Cleary PA, Teschan PE, Lorenz RA, Molitch ME, Mitch WE, Siebert C, Hall PM, et al.

J Am Soc Nephrol. 1993 Nov;4(5):1159-71.

17.

Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Mogensen CE.

Br Med J (Clin Res Ed). 1982 Sep 11;285(6343):685-8.

18.
19.

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.

Parving HH, Andersen AR, Smidt UM, Svendsen PA.

Lancet. 1983 May 28;1(8335):1175-9.

PMID:
6133986
20.

The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus.

Borch-Johnsen K, Andersen PK, Deckert T.

Diabetologia. 1985 Aug;28(8):590-6.

PMID:
4054448

Supplemental Content

Support Center